# Clinica Sierra Vista

Health Center, CA
Page: https://astrelis.co/providers/health_center/921173  
This twin: https://astrelis.co/providers/health_center/921173.md  
CMS Certification Number (CCN): 921173  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2020 to 2022)

Filings that are not a full fiscal year: FY2020 covers 229 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 159,540. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2022):** -20.0%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 39. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 9.0%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2022):** $111.8M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2022):** +3.6%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### CLINICA SIERRA VISTA, CA

Match to this profile: matched by name (method: name and state).

- FY ending 2025-03-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-03-GSAFAC-0000419570
- FY ending 2024-03-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-03-GSAFAC-0000403117
- FY ending 2023-03-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-03-GSAFAC-0000015856

| Line | FY ending 2025-03-31 | FY ending 2024-03-31 | FY ending 2023-03-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 24,223,163 [derived, p.5] | 10,288,464 [derived, p.6] | 29,768,796 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 16,149,827 [derived, p.5] | 16,089,569 [derived, p.6] | 9,056,862 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 13,512,332 [derived, p.5] | 11,808,740 [derived, p.6] | 10,705,624 [derived, p.6] |
| other current assets (Statement of financial position) | 1,434,432 [derived, p.5] | 1,672,481 [derived, p.6] | 1,536,534 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 55,319,754 [extracted, p.5] | 39,859,254 [extracted, p.6] | 51,067,816 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 49,788,719 [derived, p.5] | 50,446,718 [derived, p.6] | 52,237,871 [derived, p.6] |
| other long-term assets (Statement of financial position) | 44,386,351 [derived, p.5] | 43,005,054 [derived, p.6] | 42,126,800 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 149,494,824 [extracted, p.5] | 133,311,026 [extracted, p.6] | 145,432,487 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 27,975,991 [derived, p.6] | 28,160,158 [derived, p.7] | 18,580,393 [derived, p.7] |
| deferred revenue (Statement of financial position) | 5,073,743 [derived, p.6] | 3,690,605 [derived, p.7] | 1,271,702 [derived, p.7] |
| current debt and leases (Statement of financial position) | 1,712,773 [derived, p.6] | 1,451,580 [derived, p.7] | 1,450,294 [derived, p.7] |
| other current liabilities (Statement of financial position) | 6,337,212 [derived, p.6] | 3,168,606 [derived, p.7] | 17,157,056 [derived, p.7] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 41,099,719 [extracted, p.6] | 36,470,949 [extracted, p.7] | 38,459,445 [extracted, p.7] |
| long-term debt and leases (Statement of financial position) | 37,619,245 [derived, p.6] | 38,592,591 [derived, p.7] | 37,596,195 [derived, p.7] |
| other long-term liabilities (Statement of financial position) | 4,464,900 [derived, p.6] | 3,538,530 [derived, p.7] | 1,642,261 [derived, p.7] |
| TOTAL LIABILITIES (Statement of financial position) | 83,183,864 [extracted, p.6] | 78,602,070 [extracted, p.7] | 77,697,901 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | 66,310,960 [derived, p.6] | 54,438,661 [derived, p.7] | 67,568,586 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | 270,295 [derived, p.7] | 166,000 [derived, p.7] |
| TOTAL NET ASSETS (Statement of financial position) | 66,310,960 [extracted, p.6] | 54,708,956 [extracted, p.7] | 67,734,586 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 174,214,048 [derived, p.7] | 141,066,439 [derived, p.8] | 107,809,033 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | 3,103,126 [derived, p.8] | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 69,683,914 [derived, p.7] | 66,980,895 [derived, p.8] | 73,923,888 [derived, p.8] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 505,893 [derived, p.7] | 1,772,055 [derived, p.8] | 1,402,912 [derived, p.8] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 244,403,855 [extracted, p.7] | 212,922,515 [extracted, p.8] | 183,135,833 [extracted, p.8] |
| salaries and benefits (Statement of activities) | 148,447,399 [derived, p.7] | 144,306,220 [derived, p.8] | 116,669,642 [derived, p.8] |
| supplies and pharmaceuticals (Statement of activities) | 21,653,885 [derived, p.7] | 19,925,820 [derived, p.8] | 12,154,928 [derived, p.8] |
| purchased and professional services (Statement of activities) | 39,354,011 [derived, p.7] | 31,387,132 [derived, p.8] | 26,758,195 [derived, p.8] |
| occupancy (Statement of activities) | 9,229,266 [derived, p.7] | 13,519,663 [derived, p.8] | 8,384,950 [derived, p.8] |
| depreciation and amortization (Statement of activities) | 4,889,143 [derived, p.7] | 4,827,058 [derived, p.8] | 4,830,300 [derived, p.8] |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | 9,683,414 [derived, p.7] | 12,295,891 [derived, p.8] | 8,200,191 [derived, p.8] |
| TOTAL EXPENSES (Statement of activities) | 233,257,118 [extracted, p.7] | 226,261,784 [extracted, p.8] | 176,998,206 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | 11,146,737 [extracted, p.7] | -13,339,269 [extracted, p.8] | 6,137,627 [extracted, p.8] |
| non-operating and other changes (Statement of activities) | 455,267 [derived, p.7] | 313,639 [derived] | -1,229,093 [derived] |
| CHANGE IN NET ASSETS (Statement of activities) | 11,602,004 [extracted, p.7] | -13,025,630 [extracted, p.9] | 4,908,534 [extracted, p.9] |
| net assets, beginning (Statement of activities) | 54,708,956 [extracted, p.7] | 67,734,586 [extracted, p.9] | 62,826,052 [extracted, p.9] |
| net assets, end (Statement of activities) | 66,310,960 [extracted, p.7] | 54,708,956 [extracted, p.9] | 67,734,586 [extracted, p.9] |

| Ratio | FY ending 2025-03-31 | FY ending 2024-03-31 | FY ending 2023-03-31 |
|---|---:|---:|---:|
| Days cash on hand | 39 days [plausible] | 17 days [plausible] | 63 days [plausible] |
| Current ratio | 1.35x [plausible] | 1.09x [plausible] | 1.33x [plausible] |
| Operating margin | 4.6% [plausible] | -6.3% [plausible] | 3.4% [plausible] |
| Total margin | 4.7% [plausible] | -6.1% [plausible] | 2.7% [plausible] |
| Patient revenue share | 71.3% [plausible] | 66.3% [plausible] | 58.9% [plausible] |
| Grant dependency | absent [not computed] | 32.9% [plausible] | absent [not computed] |
| Salaries share | 63.6% [plausible] | 63.8% [plausible] | 65.9% [plausible] |
| Days in patient receivables | 34 days [plausible] | 42 days [plausible] | 31 days [plausible] |
| Debt to net assets | 0.59x [plausible] | 0.73x [plausible] | 0.58x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Probable). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (CLINICA SIERRA VISTA; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Clinica Sierra Vista", https://astrelis.co/providers/health_center/921173, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.